Automatic Speech Classifier for Mild Cognitive Impairment and Early Dementia

2022 ◽  
Vol 3 (1) ◽  
pp. 1-11
Author(s):  
Flavio Bertini ◽  
Davide Allevi ◽  
Gianluca Lutero ◽  
Danilo Montesi ◽  
Laura Calzà

The World Health Organization estimates that 50 million people are currently living with dementia worldwide and this figure will almost triple by 2050. Current pharmacological treatments are only symptomatic, and drugs or other therapies are ineffective in slowing down or curing the neurodegenerative process at the basis of dementia. Therefore, early detection of cognitive decline is of the utmost importance to respond significantly and deliver preventive interventions. Recently, the researchers showed that speech alterations might be one of the earliest signs of cognitive defect, observable well in advance before other cognitive deficits become manifest. In this article, we propose a full automated method able to classify the audio file of the subjects according to the progress level of the pathology. In particular, we trained a specific type of artificial neural network, called autoencoder, using the visual representation of the audio signal of the subjects, that is, the spectrogram. Moreover, we used a data augmentation approach to overcome the problem of the large amount of annotated data usually required during the training phase, which represents one of the most major obstacles in deep learning. We evaluated the proposed method using a dataset of 288 audio files from 96 subjects: 48 healthy controls and 48 cognitively impaired participants. The proposed method obtained good classification results compared to the state-of-the-art neuropsychological screening tests and, with an accuracy of 90.57%, outperformed the methods based on manual transcription and annotation of speech.

2019 ◽  
Author(s):  
Jill Hagenkord ◽  
Birgit Funke ◽  
Emily Qian ◽  
Madhuri Hegde ◽  
Kevin B Jacobs ◽  
...  

Testing asymptomatic individuals for unsuspected conditions is not new to the medical and public health communities and protocols to develop screening tests are well-established. However, the application of screening principles to inherited diseases presents unique challenges. Unlike most screening tests, the natural history and disease prevalence of most rare inherited diseases in an unselected population are unknown. It is difficult or impossible to obtain a “truth set” cohort for clinical validation studies. As a result, it is not possible to accurately calculate clinical positive and negative predictive values for “likely pathogenic” genetic variants, which are commonly returned in genetic screening assays. In addition, many of the genetic conditions included in screening panels do not have clinical confirmatory tests. All of these elements are typically required to justify the development of a screening test, according to the World Health Organization screening principles. Nevertheless, as the cost of DNA sequencing continues to fall, more individuals are opting to undergo genomic testing in the absence of a clinical indication. Despite the challenges, reasonable estimates can be deduced and used to inform test design strategies. Here, we review test design principles and apply them to genetic screening.


2019 ◽  
Author(s):  
Jill Hagenkord ◽  
Birgit Funke ◽  
Emily Qian ◽  
Madhuri Hegde ◽  
Kevin B Jacobs ◽  
...  

Testing asymptomatic individuals for unsuspected conditions is not new to the medical and public health communities and protocols to develop screening tests are well-established. However, the application of screening principles to inherited diseases presents unique challenges. Unlike most screening tests, the natural history and disease prevalence of most rare inherited diseases in an unselected population are unknown. It is difficult or impossible to obtain a “truth set” cohort for clinical validation studies. As a result, it is not possible to accurately calculate clinical positive and negative predictive values for “likely pathogenic” genetic variants, which are commonly returned in genetic screening assays. In addition, many of the genetic conditions included in screening panels do not have clinical confirmatory tests. All of these elements are typically required to justify the development of a screening test, according to the World Health Organization screening principles. Nevertheless, as the cost of DNA sequencing continues to fall, more individuals are opting to undergo genomic testing in the absence of a clinical indication. Despite the challenges, reasonable estimates can be deduced and used to inform test design strategies. Here, we review test design principles and apply them to genetic screening.


2019 ◽  
Author(s):  
Jill Hagenkord ◽  
Birgit Funke ◽  
Emily Qian ◽  
Madhuri Hegde ◽  
Kevin B Jacobs ◽  
...  

Testing asymptomatic individuals for unsuspected conditions is not new to the medical and public health communities and protocols to develop screening tests are well-established. However, the application of screening principles to inherited diseases presents unique challenges. Unlike most screening tests, the natural history and disease prevalence of most rare inherited diseases in an unselected population are unknown. It is difficult or impossible to obtain a “truth set” cohort for clinical validation studies. As a result, it is not possible to accurately calculate clinical positive and negative predictive values for “likely pathogenic” genetic variants, which are commonly returned in genetic screening assays. In addition, many of the genetic conditions included in screening panels do not have clinical confirmatory tests. All of these elements are typically required to justify the development of a screening test, according to the World Health Organization screening principles. Nevertheless, as the cost of DNA sequencing continues to fall, more individuals are opting to undergo genomic testing in the absence of a clinical indication. Despite the challenges, reasonable estimates can be deduced and used to inform test design strategies. Here, we review test design principles and apply them to genetic screening.


2020 ◽  
Author(s):  
Muhammad Saqib ◽  
Saeed Anwar ◽  
Abbas Anwar ◽  
Lars petersson ◽  
Michael Blumenstein

The COVID-19 is a highly contagious viral infection which played havoc on everyone's life in many different ways. According to the world health organization and scientists, more testing potentially helps governments and disease control organizations in containing the spread of the virus. The use of chest radiographs is one of the early screening tests to determine the onset of disease, as the infection affects the lungs severely. This study will investigate and automate the process of testing by using state-of-the-art CNN classifiers to detect the COVID19 infection. However, the viral could of many different types; therefore, we only regard for COVID19 while the other viral infection types are treated as non-COVID19 in the radiographs of various viral infections. The classification task is challenging due to the limited number of scans available for COVID19 and the minute variations in the viral infections. We aim to employ current state-of-the-art CNN architectures, compare their results, and determine whether deep learning algorithms can handle the crisis appropriately. All trained models are available at https://github.com/saeed-anwar/COVID19-Baselines


2016 ◽  
Vol 2016 ◽  
pp. 1-9 ◽  
Author(s):  
Bassam H. Rimawi ◽  
Lisa Haddad ◽  
Martina L. Badell ◽  
Rana Chakraborty

All HIV-infected women contemplating pregnancy should initiate combination antiretroviral therapy (cART), with a goal to achieve a maternal serum HIV RNA viral load beneath the laboratory level of detection prior to conceiving, as well as throughout their pregnancy. Successfully identifying HIV infection during pregnancy through screening tests is essential in order to preventin uteroand intrapartum transmission of HIV. Perinatal HIV transmission can be less than 1% when effective cART, associated with virologic suppression of HIV, is given during the ante-, intra-, and postpartum periods. Perinatal HIV guidelines, developed by organizations such as the World Health Organization, American College of Obstetricians and Gynecologists, and the US Department of Health and Human Services, are constantly evolving, and hence the aim of our review is to provide a useful concise review for medical providers caring for HIV-infected pregnant women, summarizing the latest and current recommendations in the United States.


2017 ◽  
Vol 2017 ◽  
pp. 1-7 ◽  
Author(s):  
Zablon K. Njiru ◽  
Cecilia K. Mbae ◽  
Gitonga N. Mburugu

The World Health Organization has targeted Human African Trypanosomiasis (HAT) for elimination by 2020 with zero incidence by 2030. To achieve and sustain this goal, accurate and easy-to-deploy diagnostic tests for Gambian trypanosomiasis which accounts for over 98% of reported cases will play a crucial role. Most needed will be tools for surveillance of pathogen in vectors (xenomonitoring) since population screening tests are readily available. The development of new tests is expensive and takes a long time while incremental improvement of existing technologies that have potential for xenomonitoring may offer a shorter pathway to tools for HAT surveillance. We have investigated the effect of including a second set of reaction accelerating primers (stem primers) to the standardT. brucei gambienseLAMP test format. The new test format was analyzed with and without outer primers. Amplification was carried out using Rotorgene 6000 and the portable ESE Quant amplification unit capable of real-time data output. The stem LAMP formats indicated shorter time to results (~8 min), were 10–100-fold more sensitive, and indicated higher diagnostic sensitivity and accuracy compared to the standard LAMP test. It was possible to confirm the predicted product using ESE melt curves demonstrating the potential of combining LAMP and real-time technologies as possible tool for HAT molecular xenomonitoring.


2005 ◽  
Vol 105 (5, Part 1) ◽  
pp. 1151-1152 ◽  
Author(s):  
Jeltsje S. Cnossen ◽  
Ben W. Mol ◽  
Joris A. M. van Der Post ◽  
Patrick M. M. Bossuyt ◽  
Gerben ter Riet

2021 ◽  
Vol 15 (5) ◽  
pp. 947-950
Author(s):  
Zertaj Kashif ◽  
Aman ur Rehman ◽  
Sonia Zafar Warriach ◽  
Muhammad Bilal Pasha ◽  
Zoya Khan ◽  
...  

Cervical cancer is the third most common cancer and the fourth dominant cause of cancer related death in women throughout the globe. Eighty percent of cases occur in the developing nations1,2. The extent of this cancer is tough to be evaluated in Pakistanbecause of differing insufficient epidemiological figures obtainable in small scale studies, dealing only reported limited number of cases which are not representative of its true burden3,4,5. As stated by World Health Organization, in 2002, the pervasiveness of cervical cancer in Pakistan was 9 in 100,000; in 2008 it jumped up to 19.5/100,000. Claimed by various studies, this cancer is among the list of first ten frequent cancers in Pakistan6,7,8,9. It is one of the most avoidable cancers nowadays and we have all the tools to eradicate it, still the number of lives lost due to cervical cancer is very high in Pakistan as it is an ignored ailment here in terms of screening, prevention and vaccination9. Economically developed countries who invested capitals for organized screening projects have made notable progress in reducing both occurrence and mortality due to this specific cancer10. The out of proportion load of cervical cancer in developing countries is largely attributable to scarcity of functional screening projects11. In our over 500 bedded teaching hospital with a well running gynecology outdoor, we do receive cervical biopsies positive for invasive malignancies but hardly receive any Pap smear tests in laboratory that prompted us to check for cervical cancer screening especially Pap smear test related awareness among our non-medical ladies.As the foundation of cervical cancer eradication is screening and prevention, each country and its regions must device an elimination plan that fits into its own culture and geographic landscape. Keywords: perception and understanding of existing screening tests, preventive measures, cervical cancer


Author(s):  
Muhammad Saqib ◽  
Saeed Anwar ◽  
Abbas Anwar ◽  
Lars petersson ◽  
Michael Blumenstein

The COVID-19 is a highly contagious viral infection which played havoc on everyone's life in many different ways. According to the world health organization and scientists, more testing potentially helps governments and disease control organizations in containing the spread of the virus. The use of chest radiographs is one of the early screening tests to determine the onset of disease, as the infection affects the lungs severely. This study will investigate and automate the process of testing by using state-of-the-art CNN classifiers to detect the COVID19 infection. However, the viral could of many different types; therefore, we only regard for COVID19 while the other viral infection types are treated as non-COVID19 in the radiographs of various viral infections. The classification task is challenging due to the limited number of scans available for COVID19 and the minute variations in the viral infections. We aim to employ current state-of-the-art CNN architectures, compare their results, and determine whether deep learning algorithms can handle the crisis appropriately. All trained models are available at https://github.com/saeed-anwar/COVID19-Baselines


2020 ◽  
Vol 3 (4) ◽  
pp. 312-318
Author(s):  
Valdir Gomes Barbosa Júnior ◽  
Roberto José da Silva Badaró ◽  
Bruna Aparecida Souza Machado

In March 2020, the World Health Organization (WHO) declared COVID-19 as a pandemic. Diagnostic and screening tests have been important tools for the clinical characterization of diseases such as COVID-19. This study aimed to analyze the presence of Brazilian manufacturers in the COVID-19 products approved by the Brazilian Health Regulatory Agency (ANVISA). This research used the ANVISA database, in which 329 registered products were identified. We classified them into 4 methods, 3 of which were the object of careful analysis. The results showed Brazil’s external dependence on products from other countries, mainly from China.    


Sign in / Sign up

Export Citation Format

Share Document